Months after delivering its crucial endorsement of the health care overhaul, the American Medical Association has found itself with fewer friends on Capitol Hill and more critics questioning its lobbying savvy
The pharmaceutical industry lobby spent $7 million in the first quarter as it lobbied the federal government
Health insurance companies are lobbying federal and state officials in an effort to ward off strict regulation of premiums and profits under the new health care law
Washington interest groups have burst back into action in hopes of bolstering or defeating a new Democratic push on health-care reform legislation
How interest groups behind health-care legislation are financed is often unclear
Insurance companies, hospitals and other health care interests have been positioning themselves in statehouses to influence the outcome of the proposed health care overhaul
Lobbyists spending big to shape health care debate
The INFLUENCE GAME: Front Group Fights Health Bill
Vita Advisors, LLC is a research-based strategic advisory firm serving the health care industry.
View more tags »